News

Business Weekly - www.businessweekly.co.uk

Cabume - www.cabume.co.uk

Vetter boosts quality and logistic processes

The pharma and biotech industries are increasingly seeking safer and more efficient supply chain processes. To meet these challenges Vetter has invested in a new, state-of-the-art Center for Visual Inspection and Logistics. The new facility offers high-bay warehousing capacity for cool and room-temperature goods employing state-of-the-art technology. The contract development and manufacturing organization (CDMO) is also setting high safety standards for quality control at the location. The 35-million-euro facility will serve as a workplace for up to 400 employees. More »
16 May 2012

AMSBIO Cultrex® 3D Culture Cell Harvesting Kit

The AMSBIO Cultrex® 3D Culture Cell Harvesting Kit is based on a non-enzymatic approach that prevents biochemical degradation during processing and overcomes the problems associated with extracting cells from 3D culture in BME or Laminin I. More »
15 May 2012

GG Eco Solutions fuels growth with a move to Chesterford Research Park

New premises within the Mansion House for renewable energy supplier More »
11 May 2012

£180m Government Funding to Bridge the ‘Valley of Death’ for Medical Breakthroughs

More »
10 May 2012

TTP Labtech Launches Impressive Number of Products Following Company Growth

New product offering demonstrates strong commitment to product development. More »
10 May 2012

Cresset to Host First North American User Group Meeting

Providing an educational and informative forum for current and prospective customers. More »
09 May 2012

Present your Company at AdvaMed 2012, 1-3 October, Boston, USA

Looking for Investors or a BizDev Partner? More »
08 May 2012

Alan Schafer to Head Population Genetics

More »
03 May 2012

New Cytotoxic Freeze Drying Capability

Winchester, UK, 11th April 2012: Biopharma Technology Ltd (BTL) have completed construction of a new standalone cleanroom, enabling them to provide freeze drying R&D services for cytotoxic products. More »
02 May 2012

Horizon Discovery and H3 Biomedicine Collaborate to Identify and Validate Novel, Patient-Relevant Cancer Targets

H3 Biomedicine to employ Horizon’s unique gene editing technology and isogenic cell lines to validate genetically defined drug targets for development of cancer therapeutics. More »
30 April 2012